Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 1
2024 pubmed

Prolonged Immunomodulator Delivery Boosts Monocyte Exosome Secretion and Elevates Cathelicidin/LL-37 Content.

Ma. Dezun D; Su. Yajuan Y; Sharma. Navatha Shree NS; Hatcher. Grant G; Ganguli-Indra. Gitali G; Indra. Arup K AK; Gombart. Adrian F AF; Xie. Jingwei J

Key Findings

  • Immunomodulator‑loaded nanofibers boost LL‑37 levels inside exosomes from THP‑1 monocytes
  • The same treatment also raises the total amount of exosomes produced
  • Exosome‑carried LL‑37 promotes skin cell proliferation, migration, endothelial tube formation, and has antibacterial effects

Practical Outcomes

  • At present the technique is a lab‑scale approach, not a DIY protocol. It hints that future topical or injectable products could use LL‑37‑rich exosomes for wound healing or infection control, but more development is needed before hobbyists can apply it.

Summary

Scientists found that soaking immune cells in special fibers loaded with vitamin D‑related compounds makes the cells release more tiny packages (exosomes) that are packed with the natural antimicrobial peptide LL‑37, and these packages help skin cells grow, blood vessels form, and kill bacteria. However, the method needs lab equipment like cell cultures and nanofibers, so it isn’t something you can do at home right now.

Abstract

Human cathelicidin LL-37 offers significant benefits to the immune system and in treating various diseases, but its therapeutic potential is hindered by low activity and instability in physiological environments. Here, we introduce a strategy to boost LL-37 levels in exosomes derived from THP-1 monocytes by incubating cells with electrospun nanofibers containing immunomodulators (e.g., 1&#x3b1;, 25-dihydroxyvitamin D<sub>3</sub> and VID400). Notably, the incubation with immunomodulator-loaded nanofibers not only increased LL-37 content in exosomes but also significantly enhanced the production of engineered exosomes. Moreover, these engineered exosomes demonstrated multiple biological activities, including promoting skin cell proliferation and migration, enhancing endothelial cell tube formation, and exhibiting antibacterial properties. Collectively, this study presents an approach to increasing both the yield of engineered exosomes and their LL-37 content, potentially offering a promising therapeutic option for wound healing, tissue regeneration, and infectious disease treatment.

Study Information

Provider

pubmed

Year

2024

Date

2024-12-19T00:00:00.000Z

DOI

10.1021/acsami.4c20695

References

41